Anti-Human SLC34A2 Reference Antibody (Upifitamab, RUO)

Description: Upifitamab (BS10414) is a research-grade recombinant antibody targeting Sodium/phosphate cotransporter 2B. Produced in mammalian cells with native-like glycosylation.
Highlights:
• Research Grade — For PK/PD studies, assay development, and ADA research.
• Native Glycosylation — Mammalian expression ensures native-like patterns.
Host species: Humanized
Isotype: IgG1-kappa
Species reactivity: Human
Immunogen:
Form: Liquid
Storage instructions:
Storage buffer: 0.01M PBS, pH7.4.
Concentration: 1mg/ml
Purity: >95% as determined by SDS-PAGE.
Clonality: Monoclonal
Applications: Research Grade Biosimilar
Target: Sodium/phosphatecotransporter2B,Na(+)-dependentphosphatecotransporter2B,Na(+)/Picotransporter2B,Sodium-dependentphosphatetransportprotein2B,NaPi3b,NaPi-2b,SLC34A2,Solutecarrierfamily34member2,Sodium-phosphatetransportprotein2B
Purification: Protein A/G purified from cell culture supernatant.
Endotoxin level: <1EU/mg, determined by LAL gel clotting assay
Expression system: Mammalian Cells
Stability and Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Alternative Names: XMT-1536,upifitamabrilsodotin,CAS:2254118-43-7
Background: Sodium-dependent phosphate transport protein 2B (SLC34A2/NaPi2b) is a ~75 kDa protein. Involved in actively transporting phosphate into cells via Na(+) cotransport.
Note: For research use only. Not suitable for clinical or therapeutic use.